PHARMACOECONOMICAL RESEARCH OF THE USE OF SORAFENIB IN MALIGNANT TUMORS by M. Y. Frolov, N. A. Avksentjev, I. G. Rusakov, E. V. Derkach

“…Pharmacoeconomic rationale for the use of sorafenib in this study is made by analyzing the impact on the budget. …”
Get full text

Haemophilia A: Pharmacoeconomic Review of Prophylaxis Treatment versus On-Demand by Brigid Unim, Maria Assunta Veneziano, Antonio Boccia, Walter Ricciardi, Giuseppe La Torre

Get full text

Pharmacoeconomics and Utilisation of Antidiabetic Medications among Type 2 Diabetes Mellitus Patients: A Longitudinal Study by Bikash Chandra Das, P Ansuman Abhisek, Deepak Choudhury, Suvendu Kumar Panda, Jayanti Prava Behera, Supriya Pradhan, Trupti Rekha Swain, Sasmita Mallick

Get full text

HEKİMLERİN FARMAKOEKONOMİ BİLGİ DÜZEYİNİN REÇETELEME DAVRANIŞINA ETKİ EDEN FAKTÖRLERLE İLİŞKİSİNİN DEĞERLENDİRİLMESİ by Enis Baha Biçer, Tolgay Ercan

Subjects: Get full text

Comparing the cost-benefit of breast cancer screening programs in rural and urban areas across four economic zones in China: a Markov modeling analysis by Dachuang Zhou, Kejia Zhou, Wenjuan Wang, Hanqiao Shao, Hongliu Zhang, Wenxi Tang

Get full text

Risk Assessment for Complex Systems Based on Fuzzy Cognitive Maps: A Case of the Biopharmaceutical Industry by Hadi Abbasian, Reza Yousefi-Zenouz, Abdollah Amirkhani, Masoud Shirzadeh, Akbar Abdollahiasl, Shekoufeh Nikfar, Mohammadreza Siahi-Shadabad, Abbas Kebriaeezadeh

Get full text

Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines by Sabine Vogler, Nina Zimmermann, Manuel Alexander Haasis, Verena Knoll, Jaime Espin, Aukje K. Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J. Wirtz, Zaheer-Ud-Din Babar

Get full text

Scalable information extraction from free text electronic health records using large language models by Bowen Gu, Vivian Shao, Ziqian Liao, Valentina Carducci, Santiago Romero Brufau, Jie Yang, Rishi J. Desai

Get full text

The Antibiotic Puzzle: Guidelines for the Family Physician by G Harding, S Field, R MacMahon, T Louie, Prairie Consensus Conference Group

“…New drugs and new classes of antibiotics are being developed and made available, and emerging resistance and pharmacoeconomics play important roles. The Canadian healthcare system presents a unique challenge for prescribing physicians because pharmacoeconomic considerations are becoming increasingly important. …”
Get full text

‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies by Sabine Vogler, Nina Zimmermann, Verena Knoll, Maximilian Salcher-Konrad, Friederike Windisch, Jaime Espin, Aukje K. Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J. Wirtz, Zaheer-Ud-Din Babar

Get full text

Screening of Trace Elements in Hair of the Female Population with Different Types of Cancers in Wielkopolska Region of Poland by Bogusław Czerny, Krzysztof Krupka, Marcin Ożarowski, Agnieszka Seremak-Mrozikiewicz

Get full text

Active and Healthy Ageing and Independent Living 2016 by Maddalena Illario, Miriam M. R. Vollenbroek-Hutten, D. William Molloy, Enrica Menditto, Guido Iaccarino, Patrik Eklund

Get full text

Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia by Abdulaali R. Almutairi PhD, Yazed Alruthia PhD, Majed S. Alyami PharmD, Omar A. Alshaya PharmD, Taif Z. Alanazi PharmD, Sarah I. Al Daghreer PharmD, Ghazwa B. Korayem PharmD, Sarah A. Alrasheed PharmD, Reema A. Alorf PharmD, Omar A. Almohammed PhD

Get full text

Reliability and validity of the Lithuanian version of headache-attributed lost time (HALT) index by I. Zagorskienė, E. Abelkis, R. Mameniškienė

“…The questionnaire was culturally adapted for Lithuanian speaking population following the recommendations of International Society for Pharmacoeconomics and Outcomes Research. Psychometric properties of HALT were tested on adults complaining of headache of any kind. …”
Get full text

Tackling Extended Hospital Stays in Patients with Acute Bacterial Skin and Skin Structure Infections by Gavin Barlow, Michael Wilke, Guillaume Béraud

“… Hospitalisation rates for acute bacterial skin and skin structure infection (ABSSSI) are rising and represent a large pharmacoeconomic burden as treatment may involve an extended number of days of antibiotic therapy. …”
Get full text

Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hos... by Laura Puzniak, Ryan Dillon, Thomas Lodise

“…We aimed to determine if available evidence from a previously conducted systematic literature review was sufficient to conduct a robust network meta-analysis (NMA) using the International Society for Pharmacoeconomics and Outcomes Research Good Practice Task Force NMA study questionnaire to evaluate suitability, relevance, and credibility of available randomized-controlled trials (RCT) of antibacterial therapies for treatment of patients with hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP). …”
Get full text

Translation and Cultural Adaptation of the ISTH-Bleeding Assessment Tool to European Portuguese by Diana Carneiro-Leão, Sofia Teixeira, Rita Queirós Pereira, Teresa Mota, Manuela Lopes, Susana Nobre-Fernandes, Fernando Araújo

“…Methods: The translation and cultural adaptation were based on the International Society for Pharmacoeconomics and Outcomes Research Guidelines and initiated after obtaining permission from the authors. …”
Get full text

Hypertension Management in Brazil: Usual Practice in Primary Care—A Meta-Analysis by Rafael V. Picon, Juvenal S. Dias-da-Costa, Flavio D. Fuchs, Maria Teresa A. Olinto, Niteesh K. Choudhry, Sandra C. Fuchs

Get full text

Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned surv... by Gang Fang, Zhipeng Pi, Yiping An, Xinxin Cao, Wei Li, Wei Li, Xiangjun Zhu, Jinxi Ding, Jinxi Ding

“…However, the comparison of their efficacy and pharmacoeconomics profiles remains limited. This study aims to evaluate the cost-effectiveness of gumarontinib versus savolitinib for the treatment of METex14 skipping NSCLC in China.MethodsA 3-state partitioned survival model (PSM) was developed with lifetime horizon from the perspective of Chinese healthcare system. …”
Get full text

Cervical cancer screening by cotesting method for Vietnamese women 25–55 years old: a cost-effectiveness analysis by Hien Thu Bui, Van Nu Hanh Pham, Thang Hong Vu

Get full text